Fetal Heart: Screening, Diagnosis and Intervention Milan Stanojevic, Cihat Sen
INDEX
Page numbers followed by f refer to figure, and t refer to table
A
A wave 144
Acquisition angle 193
Acquisition plane 193
Acquisition time 193
Adenosine 241
Alagille syndrome 247, 248, 251, 264
Alcohol 74, 251
American Academy of Pediatrics 280
Amiodarone 238, 240, 241, 244
Amphetamines 223
Anemia 223, 232, 235
Aneuploidy, overall rate of 254t
Anomalous pulmonary venous connection 118
Antiarrhythmic drugs 238t
Antibodies, autoimmune 21
Antiepileptic medications 251
Antihistaminic 232
Anxiety 223
Aorta 44, 56, 62, 63, 89, 195f, 202204, 212215
ascending 58, 64, 75, 77, 80, 83, 92, 95, 99, 101, 104106, 109, 111, 114
atretic 89
coarctation of 27, 48, 60, 63, 66, 69, 71, 7476, 110, 252255, 262, 264, 269, 281
critical-severe coarctation of 59
descending 58, 64, 110, 114, 194f, 202204, 206, 208215
interruption of 63, 66, 69, 76
maximum velocity of 147t
outflow 195f, 196
overriding 95f
pulmonary window 70
wall of 45f
Aortic annulus 64
Aortic arch 22, 56, 62, 63, 107, 110, 113, 115f, 173, 202204, 206, 208211, 211f, 212, 213, 213f, 215
anomalies 53
color Doppler sonography of 23
double 48, 59, 63
hypoplasia of 279
interrupted 48, 59, 60, 71, 75, 113, 114f, 250, 254, 264, 270
right 48, 98, 115, 116f, 210, 250
view, evaluation of 23
Aortic coarctation 48, 82f, 101f, 111f, 261
severe 48
Aortic isthmus 172
color flow of 112f
small 110
Aortic override 96
Aortic pulmonary valve stenoses 53
Aortic sac 3
Aortic stenosis 9, 26, 48, 59, 63, 74, 75, 91, 107, 108f, 109f, 252, 254, 261, 262, 264, 272
mild-to-moderate 59
supravalvular 264
Aortic valve 107, 110
Aortic width 64
Arch view 44
Arrhythmia 259, 291
Arrhythmic syndromes 232
Arterial pole 3
Arterial switch procedure 103
Arterial tortuosity syndrome 48
Arterial trunk, common 53, 74, 75
Arteriovenous anastomoses 179f
Artery
aberrant left subclavian 213
right pulmonary 58, 64, 203, 208210, 212, 213
Asphyxia 131, 148
Atresia 48, 63, 66, 67, 76, 107, 180, 269, 279
aortic 48, 59, 60, 71
duodenal 15
Atretic left inlet valve 81
Atretic mitral valve 89
Atria 34f, 43
evaluation of 19
Atrial appendages 63
Atrial chamber size 22
Atrial contraction 157
Atrial dilatation 227
Atrial ectopic beats 225
Atrial ectopy 226f, 227
perinatal management of 229
potential causes of 227
types of 226
Atrial flutter 229f, 236, 240
Atrial isomerism 234
Atrial muscle reentry 227
Atrial myocardium, enhanced automaticity of 227
Atrial natriuretic peptide 179
Atrial septal
aneurysm 48, 227, 232
defect 9, 27, 48, 59, 67, 74, 75, 77, 249, 252, 254, 260, 261, 264, 272, 286
excursion 103
tissue, lower rim of 43
Atrial septectomy 60
Atrial septum 22
Atrial ventricular M-mode tracings 228
Atrial wall, mechanical irritation of 227
Atrioventricular block 233, 239
management of 235t
perinatal management of 234
two-to-one 226f
Atrioventricular canal 1, 264
Atrioventricular conduction disease 227
Atrioventricular junction, evaluation of 20
Atrioventricular re-entry tachycardia 240
Atrioventricular septal defect 59, 61, 65, 67, 70, 7476, 253, 254, 261, 272, 286, 290
Atrioventricular valve 34f, 43, 140, 145f
color Doppler sonography of 23
regurgitation 181, 228
Atrium, enlargement of 48
Autosomal dominant 264
Autosomal recessive 264
Azygos 5
B
Balloon atrial septostomy 60
Baltimore-Washington infants study 259
Beta natriuretic peptide 162
Beta-mimetics 223
Bicuspid aortic valve 75, 110, 113, 252, 264
Bidirectional color flow 97f
Blood flow 167
direction of 125
patterns, biphasic 139
velocity 124
Blood viscosity 136
Blue spells 100
B-mode 218
Body mass index 13
Bovine jugular vein 295
Brachiocephalic artery 212, 213
Brachiocephalic vein 120
Bradycardia 233, 234
perinatal management of 234
Brain natriuretic peptide 179
Brugada syndrome 232
Bulbus cordis 3
C
Caffeine 232
excess consumption of 227
Carbamazepine 13
Cardiac anomaly 60, 248t
diagnostic ultrasound features of 65t
functional 235
Cardiac apex 19
Cardiac axis
abnormal 21
and situs 22
Cardiac conduction system, development of 4
Cardiac cycle 132, 139
Cardiac defects 247
Cardiac dysfunction 243
Cardiac function 140, 157
Cardiac malformations 256
Cardiac morphogenesis 1, 6
Cardiac myocytes 4
Cardiac position, abnormal 21
Cardiac remodeling 161
Cardiac structures, measurements of 58f
Cardiac tumor 48, 228, 232
Cardiac valves, development of 4
Cardiofaciocutaneous syndrome 264
Cardiomyopathy 88, 218, 227, 228, 234, 244, 254
arrhythmogenic right ventricular 232, 235, 241, 244
dilated 218, 219, 219f
hypertrophic 74, 75, 218, 220, 221f, 232, 235, 241, 244, 264
restrictive 218
Cardiosplenic syndromes 254
Cardiovascular adaptations 174
Cardiovascular adaption 167
Cardiovascular score 182
Cardiovascular system 178
pathophysiology of 159
physiology of 156
Carotid artery, left common 212, 213
Cavum septum pellucidum 134
Central nervous system 15, 74
abnormalities 233
Cesarean section 244, 286
Char syndrome 264
Choanal atresia 249
Cholestasis 247
Chorioamnionitis 223
Chorionic villus sampling 248
Circle of Willis 136f
Cleft palate 250
Coarctation 9, 279
aortic isthmus of 112f
Cocaine 223
Colobomata 249
Color Doppler 201
Color-box scale 22
Community-wide Fetal Cardiology Program 274
Congenital cardiac
anomalies 60t
malformations 15
Congenital heart
anomalies 74t
defect 76t, 140, 254t, 259, 261t
disease 9, 18, 26, 53, 59, 191, 210, 247, 251, 267, 268, 272, 282t, 286, 286t
antenatal diagnosis of 191
epidemiology of 9
mild 59, 59t
moderate 59t
severe 59, 59t
Congenital long QT syndrome 227
Conjoined intracardiac malformations 270
Connective tissue disorder 74
Conotruncal abnormalities 272
Conotruncal anomalies 255
Conotruncal defects 3
Conotruncal malformations 118
Conotruncal ridges 3
Conotruncal septum 3
Contractile appearance 89
Copy number variations 10, 251
Cor triatriatum 81
Cord blood 241
Coronary sinus 63, 169
connection 48
Costello syndrome 264
Cot death 235
Cyanosis, persistent 291
D
Delivery
decision 241, 242
place of 69, 78, 81, 84, 86, 89, 91, 94, 96, 98, 100, 103, 105, 107, 110, 113, 115, 117, 118
room 286
simulation 285
Diabetes mellitus 21, 74, 221f, 259
Diaphragmatic hernia 15
DiGeorge syndrome 270
Digoxin 237239
toxicity 238
Dilatation 108
Dioxins 251
Diverticulum of Kommerell 211213
Dizziness 238
Donor 183
bladder of 182
twin 181
Doppler
flow 181
index 160
physics 125f
signals 131
sonography 21, 133
ultrasound 124
Down syndrome 69, 264, 270
Ductal anomalies 48
Ductal arch 62, 63
view, evaluation of 23
Ductal flow, reversed 48
Ductus arteriosus 57, 58, 60, 64, 94, 96f, 111, 114f, 116f, 167, 175, 203206, 212, 213, 215
Ductus venosus 14, 29, 130, 130f, 136, 138f, 140f, 150f, 151, 167, 175, 182, 183, 210, 211
Doppler for screening of fetal heart defects 29f
peak systolic velocity index 144t
preload index 141t, 142
pulsatility index 143t, 185
triphasic blood flow pattern of 139f
waveform, abnormal 22
Duplication syndromes 264
Dysgenesis 5
Dysrhythmias 297
E
E wave 144
Ear anomalies 249
Ebstein's anomaly 48, 59, 61, 65, 67, 68, 73, 76, 86, 87f, 88f, 261, 270, 272, 278, 281, 286
Ebstein's malformation 299
Echocardiography 18
Edward syndrome 264
Electrocardiography 185
End-diastolic flow
absent 151, 183
reverse 183
Endocardial fibroelastosis 89, 90f, 108, 108f, 234
Enteropathy, protein-losing 291
Ephedrine 231
Erythropoietin 7
Extracardiac malformations 14
Extracorporeal membrane oxygenation 286
F
Facial anomalies 247
Fatigue 238, 239
Fetal 126, 259
abdominal situs, examination of 40f
anemia 147
predict severity of 138t
arrhythmia 230f
diagnosis of 223
management of 223
presentation of 224
atrial flutter 231f
atrioventricular block 233
bradycardia, management of 235t
cardiac disease 259
cardiac function 156
cardiac volume analysis 193
chromosomal anomaly 21
circulation 131
normal 168
complete atrioventricular block 231f
deaths 274
demise 130
distress 232, 233, 235, 243
echocardiography 15, 22, 28, 39, 191, 218, 267, 283
technique of 21
extracardiac anomaly 21
growth restriction 127, 159
head 197f
heart 37f, 140, 201
defects 29f, 31
examination 19, 21, 26, 27, 31, 33f, 34f, 39
failure 88
function, assessment of 158
malformation 271
normal 201, 202f210f
pathophysiology of 159
physiology of 156
rate 173, 223, 234, 243
hemoglobin 136
hydrops 21, 227, 259
hyperthyroidism 223
hypoxemia 132
indications 21
infection 243
irregular heart rhythm
investigation of 232t
management of 232t
lamb circulation 170f
medicine 241
myocardium 157
risk factors 14
situs, assessment of 38t
supraventricular tachycardia
diagnosis of 240t
management of 240t
tachycardia 236, 237
vascular system, development of 5
ventricular tachycardia, management of 243t
Fetoplacental compartment 130
Fiber orientation 157
Fibroblast growth factor 6
Flecainide 238, 239
level 241
Flow velocity wave 124
Fluorescence in situ hybridization 251
Fontan-type operation 292
Foramen ovale 22, 57, 83, 92, 120, 167, 175, 227
color Doppler sonography of 23
dependent
pulmonary circulation 60
systemic circulation 60
flap 19
restrictive 48, 59, 286
Foramen primum 2
Four-chamber view
abnormal 21, 271
apical 43
evaluation of 23
G
Gastrointestinal system 74
Genetic 10
abnormalities 69, 78, 81, 84, 86, 89
syndromes 15, 18
common 248t
Gestational age 160
Gray-scale sonography 20
Great arteries 104
congenitally corrected transposition of 48, 59
corrected transposition of 254
D-transposition of 269, 281, 286, 287
transposition of 9, 18, 27, 48, 53, 60, 62, 66, 67, 69, 70, 7476, 102, 253, 254, 261, 262, 269
Great veins 63
Great vessels 140
Growth restricted fetus 148, 149f, 150f, 159
management of 151t
Growth retardation 249
H
Harmonic imaging 22
Heart 196f, 272
anomalies 70t
block 233, 234
defects 249
dilated 219
discordant 36f
disease
functional 227, 232
structural 227, 234, 244
failure 291
field, primary 6
rate 42, 232, 235, 241, 244
abnormal 21
rhythm 42
abnormal 21
shape of 157
univentricular 254
ventriculoarterial connections of 22
Hematological system 15
Hemiazygos veins 5
Hepatic arteries 131
Hepatic dysfunction 291
Hepatic vein 140f, 202, 204206, 208, 209, 211, 215, 228
Heterotaxy 247, 256, 290
syndrome 118
High periconceptional blood glucose levels 12
Holme's heart 91
Holt-Oram syndrome 10, 249, 251, 264
Human cardiovascular system 1
Human chorionic gonadotropin 129
Hydantoin 74
Hydrops 220, 232, 233, 235, 243
fetalis 182
presence of 234
Hypercholesterolemia 251
Hyperthyroidism 243
Hypertrophy
biventricular 107
myocardial 48
right ventricular 98
ventricular 108, 181
Hypokinesia 108
Hypoplasia 279
aortic 46, 48
genital 249
left ventricular 83f
thymic 250
Hypoplastic left heart 59, 61, 71
complex 290
syndrome 12, 48, 57, 60, 65, 67, 68, 7476, 89, 90f, 118, 210, 215f, 247, 252, 254, 255, 261, 263, 264, 269, 272, 281
outcome of 290
Hypoplastic right heart 59, 74
syndrome 48, 215f
Hypothyroidism 238
Hypovolemia 223
Hypoxia 223
I
Iliac arteries, common 5
Iliac veins, common 5
In vitro fertilization 21
Infection 223
Inferior vena cava 5, 19, 41, 58, 63, 64, 118, 130, 130f, 138, 140f, 168, 201203, 206, 207, 209, 210, 215
Inlet valve, common 69
Innominate vein 203, 204, 206
Intact atrial septum 281, 286
Intact cardiac crux 20, 38
Intact ventricular septum 83, 92, 254, 286, 290
Interventricular septum 2, 22, 30, 43
Intrauterine growth
restriction 131
retardation 233
Ischemia 228
Isomerism 69
Isotretinoin 251
Isovolumetric contraction 157
time 185
Isovolumetric relaxation 156, 157
time 185
Isthmus 110
J
Jugular veins 5
K
Karyotype, normal 251
Kick count 240
Knock-out animal model studies 4
L
Left atrium 62, 63, 77, 80, 83, 85, 87, 90, 92, 95, 99, 101, 104106, 109, 111, 114, 120, 206208, 210, 211, 293
length 64
width 64
Left ventricle 58, 62, 63, 77, 78, 80, 83, 85, 87, 90, 92, 95, 99, 101, 104106, 109, 111, 114, 120, 202208, 211, 214, 215
double-inlet 48, 59, 61, 65, 67, 68, 76, 91, 92f, 252, 290
double-outlet 59
ejection time 185
length 64
myocardial performance index 185
width 64
Left ventricular
function, abnormal 181
outflow tract 22, 44, 81
evaluation of 20, 23
Legal stimulant medications or illicit drugs, maternal use of 227
LEOPARD syndrome 221
Lithium 21, 74
carbonate 13
Live births 274
Liver function tests 235
Long QT syndrome 228, 232, 233, 235, 241, 243, 244
Long-axis function-tissue Doppler imaging 182
M
Main pulmonary artery 64, 147t
bifurcation of 56f
Major aortopulmonary collateral circulation 94
Marfan syndrome 10
Marijuana 74
Maternal beta-blocker treatment 233
Maternal connective tissue disorder 233
Maternal lupus autoantibody titers 234
Mediastinum 74
upper 195f
Mesenchymal tissues 3
Metabolic disease 21
Metallic taste 238
Microdeletion 98
syndromes 264
Middle cerebral artery 131, 132, 135f, 138t, 151
resistance index, reference values of 137t
waveforms 182
Mitral atresia 59, 61, 73, 80f, 81, 82f, 83f, 254
Mitral regurgitation 75
Mitral stenosis 110
Mitral tricuspid
annuli tissue Doppler recordings 228
valves 157
Mitral valve 63, 110, 145t
Doppler inflow 183
prolapse 75
M-mode 218, 220, 228, 236, 243
Doppler
methods 234
technique 231f
echocardiography 21
Monitor cardiac function 243
Monochorionic twins 22
Monocusp valve 295
Monophasic blood flow pattern 146f
Multiplanar presentation 194f
Multiple malformation disorder 18
Muscular ventricular septal defect 80f
Musculoskeletal system 15
Musculus trabecula septomarginalis 43
Myocardial calcification 234
Myocardial dysfunction 234
Myocardial performance index 182, 185f
Myocarditis 227
Myocardium 169
function 181
Myocytes, moncontractile 4
N
Nausea 238
Nonconducted premature atrial contractions 233
Nonhydropic fetuses 237
Nonoptimal fetal position 33f
Noonan syndrome 10, 15, 221, 248, 249, 264
Nuchal translucency 11, 14, 22, 259, 271
O
Oligohydramnios 185
One-and-a-half ventricular repair 292
Outflow tract 63
development of 3
views 53
Oxygen
carbon dioxide 167
pressure of 171
P
Pain 223
Palliation 297
Partial anomalous pulmonary venous drainage 264
Parvovirus infection 219f
Patau syndrome 264
Patent ductus arteriosus 9, 27, 74, 75, 261, 264
Patent foramen ovale 80
Peak systolic velocity 134, 151
Pericardial effusion 22, 48, 88
Pericardial graft 295
Persistent truncus arteriosus 298
outcome of 298
Pesticides 251
Phenylketonuria 11, 21, 74, 259
maternal 12, 30
Phenytoin 13
Placenta 167
surface of 179f
Placental abruption 130
Placental dysfunction 148
Plastic bronchitis 291
Pneumonia, bacterial 298
Polyhydramnios 181, 185
sequence 182
Polyvalvular nodular dysplasia 75
Portal sinus 168
Portal vein 168
Power Doppler 201
Preeclampsia 130
prediction of 151
Pregnancy 260
multiple 259
outcome of 273f
terminations of 274
Premature atrial contraction 223, 225, 225f, 232
Premature ventricular contraction 228, 232
Prenatal detection rate 272t
Prenatal screening 270, 277, 282
Proarrhythmia 238
Prominent vagal tone 233
Prostaglandin
E 286
E1 288
infusion 94
E2 171
Protein, morphogenic 6
Pulmonary artery 3, 20, 39, 62, 63, 74, 77, 80, 83, 90, 92, 95, 99, 101, 105, 106, 109, 111, 114, 183, 195f, 197f, 202208, 211215, 228, 292
hypoplasia 48
left 58, 64
Pulmonary atresia 48, 59, 60, 72, 84f, 94, 95f, 96f, 254, 261, 269, 272, 281, 286
outcome of 292
Pulmonary semilunar valves 4
Pulmonary stenosis 26, 48, 59, 66, 67, 7476, 85, 91, 92, 93f, 98, 100, 101f, 180, 210, 211f, 254, 261, 262, 264, 272, 289
Pulmonary valve 4, 20, 92, 63
annulus 110
atresia 290
completely obstructed 94
syndrome, absent 48, 59, 75, 96, 97f, 254, 255
Pulmonary valvotomy 295
Pulmonary vein 34f, 63, 211, 228
abnormal connection of 48
color Doppler sonography of 23
left 120
Pulsatility index 124, 126, 129t, 151
Pulse repetition frequency scale 22
Pulse wave 228, 234, 243
Pulsed Doppler flow velocities 140
Q
QRS widening 238
QT prolongation 238, 239
Quintero stages 182
R
Regular cardiac rhythm 19
Regurgitation, aortic 75
Renal system 74
Renin-angiotensin aldosterone system 179
Restrictive ventricular septum 59
Retinoic acid 74
Retinoids 13, 21
Retrograde flow 94
Rhesus isoimmunization 131
Rhythm 219
Right atrium 58, 62, 63, 77, 80, 83, 85, 87, 90, 92, 95, 99, 101, 104106, 109, 111, 114, 120, 202211, 215
length 64
width 64
Right inlet valve regurgitation 69
Right ventricles 62, 63, 77, 78, 80, 83, 85, 87, 90, 95, 99, 101, 104106, 109, 111, 114, 120, 202206, 210, 211, 214, 215
double-outlet 12, 18, 30, 48, 53, 59, 66, 67, 69, 7476, 100, 253, 254, 269, 272, 281
length 64
width 64
Right ventricular function, abnormal 181
Right ventricular outflow tract 22, 44, 81, 99, 183, 292
evaluation of 20, 23
Rudimentary pulmonary valve leaflets 96
S
Sagittal ductal arch 56, 110, 113
Salbutamol 235
Scanning planes 69, 78, 81, 83, 86, 89, 102, 115, 116, 118
Selective serotonin reuptake inhibitors 13
Semilunar valve 146f
flow 22
peak velocities 182
Septal defect 68, 82f, 84f
Septal leaflet, displacement of 87f
Septum
primum 2, 43
secundum 2
Sick sinus syndrome 233
Single gene disorders 263, 264
Single ventricle 103, 279
complex 281
Sinus venosus types 59
Situs 40
abdominal 19
solitus 256
Sjögren syndrome 220, 233, 234, 259
Skeletal abnormalities 247
Sotalol 237239, 244
Spatial three-vessel view 202, 205f
Sphenoid bone 134
Stenosis
critical aortic 59, 60, 68, 90f, 108f
critical pulmonary 59, 60
mild-to-moderate pulmonary 59
peripheral pulmonary 264
artery 74, 75
severe 59
aortic 48, 59
pulmonary 59, 69
Stuck twin 131
Subclavian artery, left 114
Sudden cardiac death 235
Superior vena cava 3, 19, 39, 58, 63, 64, 82, 117f, 119f, 120, 169, 201205, 207213, 215, 228, 229f
Supraventricular tachycardia 88, 229f, 230f, 237
frequency distribution of 224f
perinatal management of 240
Systemic lupus erythematosus 233, 259
Systemic outflow obstruction 290t, 297
Systemic veins, color Doppler sonography of 23
Systolic dysfunction 181
T
Tachycardia 237f
atrial 236
atrioventricular 241
catecholaminergic polymorphic ventricular 232, 235, 241, 244
despite medication 241
Taussig shunt 297
Tei index 159, 161, 181, 184
Teratogen exposure 21
Terbutaline 231
Terfenadine 231
Tetralogy of Fallot 9, 18, 27, 48, 53, 59, 6669, 72, 7476, 98, 99f, 118, 247, 252254, 261, 262, 264, 269, 281, 286
outcome of 294
Thalami 134
Thalidomide 251
Thoracic aorta 131
Thoracic area, heart occupies third of 19
Thromboembolism 291
Thyroid function 243
Thyrotoxicosis, maternal 223
Time average maximal velocity 143t
Tissue 234
Doppler
imaging 159
method 230f
recording 230f
Tomographic ultrasound imaging 193, 194
Total anomalous pulmonary venous
connection 56, 59, 65, 67, 68, 71, 7476, 120f, 279
outcome of 293
return 252, 281
Toxins 260
Trachea 26, 44, 48, 116
Transannular valve 295
Transverse arch 113
Tricuspid 269
atresia 48, 61, 65, 67, 68, 72, 7476, 83, 84f, 85f, 247, 254, 261, 281
outcome of 296
atrioventricular valves 35f
dysplasia 48
regurgitation
mild-to-moderate 59
severe 59, 88, 88f
valve 63, 91, 145t
atresia 290
dysplasia 254
Ebstein's anomaly of 87f, 88f
Trimethadione 74
Trisomy 98, 248, 263
Truncus arteriosus 3, 12, 47, 48, 59, 63, 66, 69, 70, 76, 105f, 106f, 250, 253, 254, 264, 269, 272, 277279, 281, 286
Tumor, atrial 227
Turner syndrome 10, 89, 248, 263, 264
Twin
anemia-polycythemia syndrome 184
oligohydramnios 182
twin transfusion syndrome 178
placenta after laser ablation of 179f
U
Ultrasound 124, 192
Umbilical artery 151, 175, 182, 185
Doppler flow 131
Doppler studies 131
pulsatility index, reference values of 134t
resistance index, reference values of 133t
travel caudally 136
Umbilical vein 130f, 168, 175, 182
apex of 138f
Uterine artery 126, 151
Doppler waveform 127f
pulsatility index of 129t
resistance index of 128t
Uteroplacental compartment 126
V
Valproic acid 13
Valvar pulmonary stenosis, mild 9
Valvar regurgitation 182
Valvar stenosis, semilunar 56
Valve 63, 170
sparing total repair 295
Valvular stenosis, aubpulmonary 101
Vascular malformations 259
Vascular ring 48, 59
Vascular shunts 167
Vascular system development 1
Vein
ascending 120
right pulmonary 120
Vena cava 228
Ventricles 34f, 43, 48, 89
evaluation of 19
Ventricular dysfunction 228, 297
Ventricular dysrhythmia 236
Ventricular ectopic beats 228
Ventricular ectopy, perinatal management of 229
Ventricular end-diastolic volume 297
Ventricular morphology 22
Ventricular septal defect 9, 27, 46f, 48, 61, 65, 67, 68, 70, 7478, 79f, 80, 83, 101, 105, 105, 214, 249, 252254, 260, 261, 264, 272, 280, 286
large 59
small 59
Ventricular septum intact 20, 38
Ventricular systole 139
Ventricular tachycardia 243
perinatal management of 243
Ventriculoarterial discordance 297
Viral infection 148, 227, 259
Viral titers 234
Visual disturbance 238
Vomiting 238
W
Williams syndrome 248250
Williams–Beuren syndrome 264
World Health Organization 191
Z
Z-scores 22, 94
×
Chapter Notes

Save Clear


Human Cardiovascular System Development and Cardiac MorphogenesisCHAPTER 1

Emre Zafer
There is substantial nutritional and oxygen need for the embryo proportional to its astounding developing pace. Thus, it is not surprising that heart is the first organ begins to function.1 This process works fast enough to give rise a functioning heart by the fourth week of development. Vascular system development co-occurs with heart formation to take on the distribution of these necessities. At the third week of embryogenesis, specialized cell lineages that are destined to become heart and outflow tracts organize to form two angioblastic cords.2 Each cord is continuous with dorsal aorta cranially, and with vittelo-umbilical vein caudally.3 These cords become primitive tubes with tubular formation. Primitive tubes, the first evidence of a developing heart at the level of tissue organization, fuse along and create a single tubular heart primordium. Hyaluronate rich and cell free extracellular matrix, sometimes named “cardiac jelly,” fills tubular heart. This primordial tubular structure continues to elongate and enlarge. At certain time, it bends over itself and brings the arterial (cranial) and venous (caudal) poles close to each other. This process is called looping, which is, in part, caused by unequal evolvement speed of the two tubular ends. Also, inward bending of splanchnic mesoderm helps this process.4,5 Several genes and pathways have been identified by means of animal models and gene knock-out research that play crucial roles in tubular fusion and looping processes.
Initially, the heart is attached to the dorsal part of the developing embryo. However, this mesenteric attachment disappears soon and heart becomes suspended between its two ends: arterial outflow end is anchored by pharyngeal arches and venous pole is by the septum transversum.
 
PARTITIONING: ATRIOVENTRICULAR CANAL AND ATRIA
Inside the developing tubular heart, at the dorsal and ventral aspects of the future atrioventricular (AV) canal, tissue accumulations are being noticed. These aggregations are called as endocardial cushions. By continuous 2proliferation from dorsal and ventral walls, eventually they merge into each other in the middle of the canal. In doing so, AV canal is separated into left and right portions. Endocardial cushions further transform into valves and into membranous segment of the septum by proliferation of specialized cell lineages under the complex process of transcription factor signaling.
At the beginning, atrium is a large unseptated cavity. This common primordial atrium is separated by two different septa into right and left atria in successive and overlapping processes. These septa are called septum primum and septum secundum, named in the order of their appearance. Septum primum, a membranous septum, partially divides the common primordial atrium into right and left chambers. The incomplete division at the endocardial cushion region creates an opening called as foramen primum. While foramen primum gradually closes down, small holes are formed as a consequence of regional apoptosis upon completion of septal formation. These holes merge to become foramen secundum. Soon after the completion of septum primum, septum secundum begins to develop. At this stage, septum primum begins to disappear. Septum secundum contains more muscle fiber. It grows very close to the septum primum, in a position that almost attached to it. The nonoverlapped portion of both septa (between the disappearing primum and newly developed secundum) is left open and called as foramen ovale. Through these foramens, blood with higher oxygen saturation bypasses fetal lungs and flows from right to left atrium. Caudal remnant of septum primum serves as a valve and it can be appreciated during fetal echocardiography while swinging into left atrium. Significant changes in cardiovascular dynamics occur at the time of birth that cause foramen ovale to close in approximately 96 hours.
During atrial partitioning, transformation and incorporation of sinus venosus into atrium occurs. Auricles are formed as ridged muscular pockets in each atrium. Later, endocardial cells transform into mesenchymal cells to invade extracellular matrix. Then endocardial cushions contribute to the formation of valves and membranous part of interventricular septum (IVS).
 
VENTRICULAR PARTITIONING
Ventricular septal formation occurs at the seventh week of embryogenesis. However, heart begins to contract prior to this point. Adult IVS has muscular and membranous segments. Muscular segment begins to appear as a ridge in ventricular floor. As discussed previously, it grows toward endocardial cushions and together they divide common ventricle into right and left ventricles. At very early stages of the first trimester, a small opening in IVS near the endocardial cushions lets interventricular blood passage until the seventh week of gestation. Membranous part of the IVS that originates from endocardial cushions merges with expanding muscular IVS and this small opening is closed. 3Prior to this final process, ventricular separation is completed. Importantly, this segment of IVS shows continuation with the conotruncal septum that lies between aorta and main pulmonary artery. In clinical practice, visualization of membranous IVS may sometimes be insufficient secondary to echolucent artifacts during ultrasound evaluation of the fetal heart. Hence, the suspicion of a ventricular septal defect during fetal echocardiography in four chamber view can be ruled out by visualization of normal left ventricular outflow tract.
 
SINUS VENOSUS
Venous entrance of primordial atria is noticed as a bulbous enlargement of the looped primordial heart and it is called “sinus venosus.” Its opening soon takes part in the right atrium after partitioning of common atrial primordium. Sinus venosus collects venous drainage from bilateral vitellin, umbilical and cardinal veins. As embryo develops and venous return increases, two bulges appear in sinus venosus and they are called right and left horns of sinus venosus. With changing blood flow dynamics along with complex transcriptional regulation, the right horn develops into superior vena cava (SVC) and the left one into coronary sinus.3 Other than their contribution to systemic venous return, sinus horns also involve in sinoatrial node development.6
 
DEVELOPMENT OF OUTFLOW TRACT
 
Bulbus Cordis and Truncus Arteriosus
As sinus venosus plays significant role in atrial partitioning at the venous pole, bulbus cordis has similar anatomic importance for outflow tract development at the arterial pole. Aortic sac, which gives rise to the aortic arches superiorly, connects to the bulbus cordis of developing tubular heart. This bulbar structure is continued with truncus arteriosus (common trunk), which is a primordial origin of aorta and main pulmonary artery.
The septum that separates truncus arteriosus into aorta and main pulmonary artery (conotruncal septum) is originated from mesenchymal tissues in bulbus cordis. Two regional proliferations begin to appear and they are called as ridges (bulbar and truncal or conotruncal ridges). With continuous proliferation and extension, they meet in the middle to create two lumens. Cardiac neural crest cells also involve in this process along with other regional cell lineages. The term of “conotruncal defects” refers to the developmental abnormalities of conus (the segment of bulbus arteriosus close to the developing heart) and truncus (the farther segment of bulbus cordis). An inverted rotation of conotruncus would lead to the transposition of great arteries, one of the common cyanotic congenital heart defects.7
In the proximal part of outflow tract, endocardial cushions meet in the middle and fuse to separate the common trunk. Conversely, distal outflow tract separation is achieved by the migration of cardiac neural crest cell 4population.8 During internal and longitudinal separation of common trunk into aorta and pulmonary trunk, the whole outflow structure twists around itself. This spiraling process eventually gives itself a unique orientation that can be appreciated during fetal echocardiography, in three-vessel view. As embryonic development continues, bulbus cordis is eventually incorporated in ventricles.
 
DEVELOPMENT OF CARDIAC VALVES
Aortic and pulmonary semilunar valves are the first set of valves to form. They develop by the protrusion of subendocardial tissues located in respective regions. This process begins after the complete longitudinal separation of truncus arteriosus. Distal outflow tract and intercalated cushions set the stage for ventriculoarterial valve development. Knock-out animal model studies have shown that Tbx1 gene is crucial for the fusion of these outflow cushions and for the formation of separate valves.9 Aortic and pulmonary valves each consist of three leaflets.
Initially endocardial cushions serve as primitive valves for blood to flow in one direction.10 Soon, mitral and tricuspid valves develop from regional tissue swellings at endocardial cushions. Mitral and tricuspid valves have two and three cusps, hence the name bicuspid and tricuspid valves, respectively. These leaflets are derived from endothelial layer of primordial heart tube where specific cell population undergoes mesenchymal transformation. Studies have shown that epithelial layer also contribute to AV valvar development.9 Papillary muscles are thought to be originated by further condensation of local trabeculations. Papillary muscles attach to the cusps of AV valves via the chordae tendineae.
 
DEVELOPMENT OF CARDIAC CONDUCTION SYSTEM
Since all cardiac myocytes of the developing heart have pacemaker abilities initially, contractions begin in tubular primordium even before looping process sets up. Usually, a regular rhythm is established during the fifth week of development with ventricular contractions following atrial contractions.11,12 However, earlier to this point, common primordial atrium originated peristalsis helps blood to move forward at around 23rd day of embryogenesis.2,3 Shortly, sinus venosus takes over this task until specialized cell lineages of noncontractile myocytes accrete and begin to function as sinoatrial node in the right atrial primordium. This specific cell group connects with separately developing AV node to create a bundle. AV bundle fibers grow and divide into two ventricular branches just after their entrance to ventricles. Sinoatrial node is located in the right atrium and AV node is in close proximity to endocardial cushions, at the right side of the interatrial septum. Even finer and wider distribution 5throughout the ventricles is achieved by penetrating His bundle and Purkinje fibers that are in part originated from cardiogenic mesoderm and epicardial surface.35
 
DEVELOPMENT OF FETAL VASCULAR SYSTEM
The venous return to future atria occurs from three sources: common cardinal, vitellin and umbilical veins. Vitelline veins regress after embryonic period.11 Cardinal veins collect blood from developing body of the embryo. They are formed inferiorly and superiorly in bilateral fashion. When they join each other, they form right and left common cardinal veins. Part of the left common cardinal vein persists and forms coronary sinus. It receives drainage from most epicardial ventricular veins and empties directly into the right atrium. However, coronary vasculature is one of the last developing structures of embryonic heart.13
The brachiocephalic vein is formed by the anastomosis of right and left superior cardinal veins. SVC and internal jugular veins are formed by superior cardinal veins also. Inferior vena cava (IVC), common iliac veins, renal, suprarenal, gonadal, azygos and hemiazygos veins develop from the respective segments of subcardinal and cardinal veins during their sequential appearance and disappearance. Dysgenesis or abnormalities in these sequential events may lead to vascular developmental anomalies such as persistent SVC, segmental atresia of IVC and double IVC or double SVC.
As the third source of venous return to primordial atrium, umbilical veins provide highly oxygenated blood for developing embryo. Umbilical vein and the IVC are connected via ductus venosus. With adequate pressure, a great volume of blood with high nutrient and oxygen content bypasses the liver and reaches to IVC. A sphincter mechanism in ductus venosus helps to regulate the amount of blood flow directed to IVC and fetal liver. Also, IVC collects blood from caudal part of the embryo. One of the paired umbilical veins disappears in the early first trimester.
The development of aortic root and the ascending aorta has been discussed in the outflow partitioning topic. Another bypass mechanism, ductus arteriosus connects pulmonary trunk to aorta, redirects the majority of right ventricular output into systemic circulation. Aortic arches stem from aortic sac and they supply pharyngeal arches. Body of aorta develops from fused pair of two dorsal vessel primordia. It successively gives many branches along the body of developing embryo such as intercostal, vertebral, lumbar and common iliac arteries. Internal iliac arteries arise from aorta via umbilical arteries. Even yolk sac and chorion are supplied by aorta.
In the embryonic-fetal life, a small percentage of blood flow is directed toward lungs. Accordingly, there is a small amount of venous return from lungs to primordial left atrium carried by pulmonary veins. The origin of the pulmonary vein is incorporated into dorsal atrial wall during atrial 6partitioning; pulmonary vein primordium has been showed to contain traces of atrial myoblasts. Soon, four separate pulmonary veins develop in the mediastinal mesenchyme.
 
CARDIAC MORPHOGENESIS
From early progenitor cells to its final three-dimensional form, regulation of cardiac development requires a complex regulatory process involving multiple signaling pathways and many transcription factors. First cells that leave the primitive streak to become heart are splanchnopleuric mesodermal cells. Surrounding local endodermal signaling systems, especially bone morphogenic protein (BMP) and WNT lead the synthesis of important transcription factors. TBX5, GATA4, BAF60c, along with other transcription factors stimulate myocardial progenitor cells to coalesce into a region called “primary heart field.”14,15 They further organize into endocardial-angioblastic strands. These bilateral tubular strands soon merge each other and form single tubular heart primordia as discussed previously. From this stage, extracardiac pharyngeal mesodermal progenitor cells (the secondary heart field) involve in and boost cardiac development along with proliferating cardiac progenitor cells. Elongation and looping are achieved by active proliferation and differentiation of early myocardial progenitor cells at the two poles of tubular heart primordium.14 Then, by means of retinoic acid effect, a specific cell population in the posterior primary heart field begins to proliferate and transform for atrial development. The lack of retinoic acid exposure in the anterior primary heart field leads to ventricular rather than atrial development by default.10 In other words; cells in the primary heart field give rise to the development of left and right atria and the left ventricle. Conversely, the cell population in the secondary heart field develop into right ventricle and outflow tract.7
While WNT, fibroblast growth factor (FGF) and Hedgehog signaling pathways are crucial for proliferative elongation and looping, inhibitor signals (such as BMP signaling at the arterial pole) are also important in cardiac morphogenesis by causing regional discordant growth.14
During the looping process, polarity of the developing heart becomes right to left.4,5 A considerable amount of transcription factors play in the field in different moments and interacts with each other for tubular heart formation, looping, elongation, ballooning and condensation processes. As an example, transcription factors Hand1, Hand2 and Pitx2 have been shown to play significant role in looping.4,5,10 Also, certain left–right patterning proteins (Nodal and Lefty-2) have been demonstrated to play a role in polarity formation. However, the underlying mechanism for the rightward looping of primordial tubular heart is poorly understood.14
Ballooning morphogenesis is an attractive model in describing early embryonic cardiac developmental stages. Atrial and ventricular primordia 7along with endocardial cushions develop as sequentially appearing proliferation niduses at respective regions. T-box family of transcription factors plays significant role in the orchestration of this region specific proliferation process.14 Also, Neuroregulin1-ErbB signaling system is believed to be involved in the formation of trabeculae and Purkinje fibers.16
Recent advances have also shed light on coronary vasculature development pathways. Coronary development involves communication between the epicardium, the subepicardial mesenchyme and the myocardium. This communication includes signaling systems such as WNT and Hedgehog, growth factors and signal molecules such as vascular endothelial growth factor, FGF, transforming growth factor-β and erythropoietin.17
The mechanisms behind many congenital cardiovascular malformations are complex. There are modifier genes, dosage sensitive genes and many transcription factors that work in several cardiac morphogenetic pathways. In many instances, it is more complicated than a simple gene mutation. As an example, majority of 22q11.2 microdeletion syndrome cases have conotruncal defects, some carry mutations in a dosage sensitive gene TBX1, others suspected to have modifier molecule abnormalities affecting sonic hedgehog and retinoic acid signaling pathways.18 Also, environmental (epigenetic) factors may contribute to the development of certain cardiovascular malformations, e.g. high glucose levels may affect secondary heart field and neural crest in pregestational diabetes.19,20
REFERENCES
  1. Srivastava D. Genetic regulation of cardiogenesis and congenital heart disease. Annu Rev Pathol. 2006;1:199–213.
  1. Moore KL, Persaud TVN, Torchia MG. The cardiovascular system. In: Moore KL, Persaud TVN, Torchia MG, (Eds). The developing human: clinically oriented embryology. 10th ed. Amsterdam: Elsevie;  2015. p. 284–334.
  1. Mirzoyev S, McLeod CJ, Asirvatham SJ. Embryology of the conduction system for the electrophysiologist. Indian Pacing Electrophysiol J. 2010;10(8):329–38.
  1. Gilbert SF. Principles of development: developmental anatomy [chapter 1]. In: Gilbert SF, (Ed). Developmental Biology. 6th edn. Sunderland (MA): Sinauer Associates;  2000. p. 1–24.
  1. Gilbert SF. Principles of development: developmental genetics [chapter 5]. In: Gilbert SF, editor. Developmental biology. 6th ed. Sunderland (MA): Sinauer Associates;  2000. p. 1–24.
  1. Norden J, Grieskamp T, Lausch E, et al. Wt1 and retinoic acid signaling in the subcoelomic mesenchyme control the development of the pleuropericardial membranes and the sinus horns. Circ Res. 2010;106(7):1212–20.
  1. Nakajima Y. Mechanism responsible for D-transposition of the great arteries: is this part of the spectrum of right isomerism? Congenit Anom (Kyoto). 2016;56(5):196–202.
  1. Martinsen BJ, Lohr JL. Cardiac development. In: Iaizzo PA, (Ed). Handbook of Cardiac Anatomy, Physiology, and Devices. Totowa, NJ: Humana Press;  2005. p. 15–23.
  1. 8 Spicer DE, Bridgeman J, Brown NA, et al. The anatomy and development of the cardiac valves. Cardiol Young. 2014;24(6):1008–22.
  1. Carlson BM. Cardiovascular system [chapter 17]. In: Carlson BM, (Ed). Human embryology and developmental biology. 5th edn. Amsterdam: Elsevier;  2014. p. 408–52.
  1. Acharya G, Gui Y, Cnota W, et al. Human embryonic cardiovascular function. Acta Obstet Gynecol Scand. 2016;95(6):621–8.
  1. Christoffels VM, Smits GJ, Kispert A, et al. Development of the pacemaker tissues of the heart. Circ Res. 2010;106(2):240–54.
  1. Gittenberger-de Groot AC, Bartelings MM, Poelmann RE, et al. Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Semin Fetal Neonatal Med. 2013;18(5):237–44.
  1. Kelly RG, Buckingham ME, Moorman AF. Heart fields and cardiac morphogenesis. Cold Spring Harb Perspect Med. 2014;4(10):a015750.
  1. Steimle JD, Moskowitz IP. TBX5: a key regulator of heart development [chapter 7]. In: Frasch M, (Ed). T-box genes in development and disease. Current topics in developmental biology, vol. 122. Amsterdam: Elsevier;  2017. p. 195–221.
  1. Lai D, Liu X, Forrai A, et al. Neuregulin 1 sustains the gene regulatory network in both trabecular and nontrabecular myocardium. Circ Res. 2010;107(6):715–27.
  1. Olivey HE, Svensson EC. Epicardial-myocardial signaling directing coronary vasculogenesis. Circ Res. 2010;106(5):818–32.
  1. Azhar M, Ware SM. Genetic and developmental basis of cardiovascular malformations. Clin Perinatol. 2016;43(1):39–53.
  1. Roest PA, van Iperen L, Vis S, et al. Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by N-acetylcysteine. Birth Defects Res A Clin Mol Teratol. 2007;79(3):231–5.
  1. Molin DG, Roest PA, Nordstrand H, et al. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Res A Clin Mol Teratol. 2004;70(12):927–38.